Search
Home
Agenda
Speakers
Companies
Sponsors
Yelp Guide
Blog/News
Session Feedback
Browse
Exhibit Hall Navigation
×
×
×
Business Development and Finance
Get Relevant or Go Home: Shedding Light on Oncology R&D Sums
107AB, Level 100
Ms. Lisa Urquhart
Editor, Vantage at
Evaluate Ltd
Curtis Hecht
Chief Business Officer at
Calithera Biosciences
Dr. Paul Juniewicz
Sr. Director, Oncology Search & Evaluation at
Takeda
Debi Watson
Vice President, Business Development and Licensing at
Johnson & Johnson Innovation, Janssen Business Development
What’s Next: The Landscape of Innovation in 2019 and Beyond
103ABC, Level 100
Barbara Dalton
Vice President, Worldwide Business Development at
Pfizer Inc.
Dr. David Donabedian
Co-founder, CEO and Director at
Axial Biotherapeutics
Chris Garabedian
Chairman and CEO at
Xontogeny, LLC
Curt Herberts
Chief Financial Officer and Chief Business Officer at
Senti Biosciences, Inc.
David Thomas
Vice President, Industry Research at
Biotechnology Innovation Organization
Ben Thorner
Senior Vice President & Head, MRL Business Development & Licensing at
Merck & Co., Inc.
Sam Ulin
Managing Director at
ClearView Healthcare Partners
Oncology
What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting
105AB, Level 100
Ted Tentoff
Sr. Research Analyst at
Piper Jaffray
Sam Agresta
Chief Medical Officer at
Infinity Pharmaceuticals
Roy Baynes
Senior Vice President, Global Clinical Development & Chief Medical Officer at
Merck Research Laboratories
Howard "Skip" Burris
President at
ASCO
Patricia Keegan
Director, Division of Oncology Products 2 at
Center for Drug Evaluation and Research (CDER), FDA
Dr. Thomas Lynch
Executive Vice President, Chief Scientific Officer at
Bristol-Myers Squibb